“Antipsychotic Use in Youth Without Psychosis: A Double-edged Sword”
This month’s issue of JAMA Psychiatry ran an editorial commenting on recent research revealing that the majority of youth prescribed antipsychotics have not been diagnosed with a mental disorder.
How Providers Can Support Psychiatric Drug Discontinuation
Supportive patient-practitioner relationships are crucial to the successful discontinuation of psychiatric medication.
Clozapine-induced Stuttering Affects 1% Of Patients
A team of psychiatrists reviewed 654 cases in West Ireland to find that nearly 1% of all patients taking the antipsychotic clozapine had experienced clozapine-induced stuttering.
Forest Labs’ Antidepressant Marketing Woes Continue
Forest Labs has been hit with a new lawsuit in Massachusetts, over misleading marketing of its antidepressant drugs Celexa and Lexapro to adolescents, even...
Study Highlights Difficulty of Antipsychotic Withdrawal
New research finds insomnia, anxiety, and depression are common symptoms of antipsychotic withdrawal, highlighting difficulties of discontinuation.
Largest Survey of Antipsychotic Experiences Reveals Negative Results
A new survey exploring antipsychotic user experience finds that more than half of the participants report only negative experiences.
Social Relationships Integral to Recovery in First Episode Psychosis
Research finds patients of first-episode psychosis report benefits from social relationships where their personhood is respected.
What is the Evidence for Empirically Supported Treatments in Psychology?
New meta-scientific review questions the evidence for the gold standard psychotherapies and empirically supported treatments.
BJP Announces “The End of the Psychopharmacological Revolution”
The editor of the British Journal of Psychiatry, in a comment on Morrison et al.'s "Antipsychotics: is it Time to Introduce Patient Choice," announces...
German Psychologists Declare “the Drugs Don’t Work”
JĂĽrgen Margraf and Silvia Schneider, both well-known psychologists at the University of Bochum in Germany, claim that psychotropic drugs are no solution to mental...
Class Action Lawsuit Granted Over Pfizer Antidepressant’s Effects on Heart, Liver and Profits
Pfizer will face a class action lawsuit by investors who claim that the drugmaker's Wyeth unit failed to disclose information about its antidepressant Pristiq's...
Therapy Beats Drugs for Depression for Long-Term Outcomes
Combining drugs and therapy also did not lead to better depression outcomes than therapy alone.
Researchers Document Protracted Withdrawal from Antidepressants
Protracted Withdrawal Syndrome characterized by long-term adverse experiences after coming off of antidepressants.
Major Risks from Drug Interactions in Common Psychiatric Polypharmacy
It is very common for psychiatric patients, especially those diagnosed with schizophrenia, to be prescribed two or more psychiatric medications at once, and this...
Is Long-term Use of Benzodiazepines a Risk for Cancer?
A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.
Adults Treated for ADHD Report Low Quality of Life
Adults receiving ADHD medications and therapy frequently experience adverse events that interfere with employment and daily life.
Antidepressant is Toxic to Fungus
Zoloft isn't just for depression any more; it also kills fungal meningitis. Researchers from Texas A&M find that "The problem for many current antifungal...
Antidepressants Actually Reduce Serotonin Levels
Common scientific beliefs about serotonin levels in depression and how antidepressants act on the brain appear to be completely backwards.
Call for Papers: Critical Underpinnings of User/Survivor Research and Co-Production
The journal Philosophy, Psychiatry & Psychology is calling for proposals for papers "aimed at tackling the 'hard' questions implicated in processes of user/survivor inclusion,...
Zoloft Does Not Improve Depression, Even in Severe Cases, Study Finds
Despite their finding, the researchers suggest that SSRIs be given to people who do not meet criteria for depression or anxiety.
Completely New Naming System for Psychotropic Drugs Proposed
A group of influential organizations are beginning an effort to change the entire way that psychiatric medications are named, according to a press release...
Canadian Study Links Cannabis and Psychosis in Youth
The Cannabis and Psychosis Awareness Project, a four-year study from Canada that was released on Tuesday, finds that smoking marijuana - particularly heavy use in...
Not an Onion Study: Laughing Gas vs Air for Treatment of Depression
"Nitrous oxide, or laughing gas, has shown early promise as a potential treatment for severe depression in patients whose symptoms don’t respond to standard therapies," stated a press release about a widely-reported study that was published in Biological Psychiatry. The press release also stated that over a third of the patients improved after being given air.
A Review of Drug-Company Funded Mental Health Websites
A meta-analysis of studies of mental health websites by John Read found that 42% are either drug company owned or receive funding from drug...
Osteoporosis Associated with Antipsychotic Treatment
Chinese researchers find, in a literature review for the International Journal of Endocrinology find an increased rate of osteoporosis among people with a schizophrenia...
